NORTH AMERICA BOTULINUM TOXIN MARKET 2021-2028

 

 TABLE OF CONTENTS

1.     NORTH AMERICA BOTULINUM TOXIN MARKET – SUMMARY         

2.     INDUSTRY OUTLOOK

1.1. KEY INSIGHTS     

1.1.1.    SURGE IN DISPOSABLE INCOME       

1.1.2.    GROWING NUMBER OF MEN OPTING FOR COSMETIC TREATMENT  

1.1.3.    DEVELOPMENT OF HEALTHCARE INFRASTRUCTURE    

1.1. IMPACT OF COVID-19 ON THE BOTULINUM TOXIN INDUSTRY 

1.2. PORTER’S FIVE FORCES ANALYSIS 

1.1.1.    THREAT OF NEW ENTRANTS   

1.1.2.    THREAT OF SUBSTITUTE         

1.1.3.    BARGAINING POWER OF SUPPLIERS

1.1.4.    BARGAINING POWER OF BUYERS     

1.1.5.    THREAT OF COMPETITIVE RIVALRY  

1.1. MARKET ATTRACTIVENESS MATRIX

1.2. VENDOR SCORECARD  

1.3. KEY MARKET STRATEGIES     

1.1.1.    NEW PRODUCT LAUNCHES     

1.1. MARKET DRIVERS         

1.1.1.    INCREASING DEMAND FOR AESTHETIC PROCEDURES 

1.1.2.    EXPANSION OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS        

1.1. MARKET RESTRAINTS   

1.1.1.    ADVERSE EFFECTS ASSOCIATED WITH BOTULINUM TOXIN  

1.1.2.    LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES 

1.1.3.    LACK OF INTERCHANGEABILITY BETWEEN BOTULINUM TOXIN PRODUCTS   

1.1. MARKET OPPORTUNITIES      

1.1.1.    INCREASING AGING POPULATION    

1.1.2.    RISE IN MEDICAL TOURISM     

1.     NORTH AMERICA BOTULINUM TOXIN MARKET – BY TYPE  

1.1. TYPE A      

1.2. TYPE B      

2.     NORTH AMERICA BOTULINUM TOXIN MARKET – BY APPLICATION    

1.1. COSMETIC APPLICATIONS      

1.1.1.    GLABELLAR LINES         

1.1.2.    LATERAL CANTHAL LINES (CROW’S FEET) 

1.1.3.    FOREHEAD LINES

1.1.4.    OTHER COSMETIC APPLICATIONS    

1.1. NON-COSMETIC APPLICATIONS       

1.1.1.    DYSTONIA  

1.1.2.    CHRONIC MIGRAINE      

1.1.3.    OPHTHALMOLOGIC DISORDERS       

1.1.4.    OTHER NON-COSMETIC APPLICATIONS     

2.     NORTH AMERICA BOTULINUM TOXIN MARKET – BY END-USER    

1.1. HOSPITALS

1.2. CLINICS AND OTHERS  

2.     NORTH AMERICA BOTULINUM TOXIN MARKET – REGIONAL OUTLOOK        

1.1. COUNTRY ANALYSIS     

1.1.1.    UNITED STATES   

1.1.2.    CANADA      

2.     COMPETITIVE LANDSCAPE 

1.1. ABBVIE INC

1.2. EVOLUS INC

1.3. GALDERMA PHARMA SA (ACQUIRED BY EQT)     

1.4. HUGEL INC

1.5. IPSEN PHARMA   

1.6. MERZ PHARMA    

1.7. MEDYTOX INC

1.8. REVANCE THERAPEUTICS INC

1.9. US WORLDMEDS LLC    

2.     METHODOLOGY & SCOPE  

1.1. RESEARCH SCOPE & DELIVERABLES        

1.2. SOURCES OF DATA      

1.3. RESEARCH METHODOLOGY  

 

 

LIST OF TABLES

 

TABLE 1: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2: MARKET ATTRACTIVENESS MATRIX

TABLE 3: VENDOR SCORECARD

TABLE 4: LIST OF NEW PRODUCT LAUNCHES

TABLE 5: NORTH AMERICA BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 6: NORTH AMERICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 7: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 8: NORTH AMERICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 9: NORTH AMERICA BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 10: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

 

 

LIST OF FIGURES

 

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: NORTH AMERICA BOTULINUM TOXIN MARKET, BY TYPE, 2020 & 2028

FIGURE 3: NORTH AMERICA BOTULINUM TOXIN MARKET, BY TYPE A, 2021-2028 (IN $ MILLION)

FIGURE 4: NORTH AMERICA BOTULINUM TOXIN MARKET, BY TYPE B, 2021-2028 (IN $ MILLION)

FIGURE 5: NORTH AMERICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2020 & 2028

FIGURE 6: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 7: NORTH AMERICA BOTULINUM TOXIN MARKET, BY GLABELLAR LINES, 2021-2028 (IN $ MILLION)

FIGURE 8: NORTH AMERICA BOTULINUM TOXIN MARKET, BY LATERAL CANTHAL LINES (CROW’S FEET), 2021-2028 (IN $ MILLION)

FIGURE 9: NORTH AMERICA BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2021-2028 (IN $ MILLION)

FIGURE 10: NORTH AMERICA BOTULINUM TOXIN MARKET, BY OTHER COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 11: NORTH AMERICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 12: NORTH AMERICA BOTULINUM TOXIN MARKET, BY DYSTONIA, 2021-2028 (IN $ MILLION)

FIGURE 13: NORTH AMERICA BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2021-2028 (IN $ MILLION)

FIGURE 14: NORTH AMERICA BOTULINUM TOXIN MARKET, BY OPHTHALMOLOGIC DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 15: NORTH AMERICA BOTULINUM TOXIN MARKET, BY OTHER NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 16: NORTH AMERICA BOTULINUM TOXIN MARKET, BY END-USER, 2020 & 2028

FIGURE 17: NORTH AMERICA BOTULINUM TOXIN MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

FIGURE 18: NORTH AMERICA BOTULINUM TOXIN MARKET, BY CLINICS AND OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 19: NORTH AMERICA BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 20: UNITED STATES BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 21: CANADA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

 

 

 

MARKET OUTLOOK

 

According to Triton Market Research, the market for botulinum toxin North America is anticipated to develop with a CAGR of 5.18% in the estimated phase between 2021 and 2028. The United States and Canada together make up the market in this region.

The Canadian market comprises a number of global and local players that intensely compete among themselves. While most people in eastern countries retire at the age of 60 years, Canadian nationals retire at the age of 65 years. Therefore, they have 5 additional years of social and professional life. This generates the desire to look younger and more energetic, which has boosted the demand for cosmetic procedures. According to the national government, people in Canada are opting for non-invasive cosmetic procedures, to reduce the appearance of facial wrinkles and enhance their looks.

Botulinum neurotoxin injections are used for both, medical as well as cosmetic reasons. In Canada, three types of botulinum toxin products are available for patients, including botulinum toxin type A. According to a 2018 report by the International Society of Aesthetic Plastic Surgery (ISAPS), there were 530 plastic surgeons present in Canada, who contribute to the nation’s botulinum toxin market. Also, Evolus, which is the exclusive sales partner of Daewoong Pharmaceutical, received approval for the marketing of Nuceiva (a botulinum toxin product), from Health Canada, in August 2018. All these factors are expected to aid the adoption of botulinum toxin in Canada, which, in turn, will fuel the studied market growth in the coming years.

 

 

COMPETITIVE OUTLOOK

 

Major players engaged in the botulinum toxin market are Hugel Inc, Galderma Pharma SA (Acquired By EQT), Medytox Inc, Ipsen Pharma, and Revance Therapeutics Inc.

 

Get more insights into the North America Botulinum Toxin Market:

 

https://www.tritonmarketresearch.com/reports/north-america-botulinum-toxin-market

 

 

SEGMENTATION

1.     ABBVIE INC     

2.     EVOLUS INC

3.     GALDERMA PHARMA SA (ACQUIRED BY EQT) 

4.     HUGEL INC

5.     IPSEN PHARMA         

6.     MERZ PHARMA

7.     MEDYTOX INC

8.     REVANCE THERAPEUTICS INC

9.     US WORLDMEDS LLC

 

 

 

 

 

Comments

Post a Comment

Popular posts from this blog

NORTH AMERICA BIOCHAR MARKET 2022-2028

    TABLE OF CONTENTS 1. NORTH AMERICA BIOCHAR MARKET - SUMMARY 2. INDUSTRY OUTLOOK 2.1. IMPACT OF COVID-19 ON BIOCHAR MARKET 2.2. KEY INSIGHTS 2.2.1. PYROLYSIS IS THE MOST COMMON TECHNIQUE FOR BIOCHAR PRODUCTION 2.2.2. AGRICULTURE DOMINATES THE APPLICATION SEGMENT 2.2.3. GROWING NEED TO AVOID BIOCHAR LOSS DURING APPLICATION AND TRANSPORTATION 2.3. PORTER’S FIVE FORCES ANALYSIS 2.3.1. THREAT OF NEW ENTRANTS 2.3.2. THREAT OF SUBSTITUTES 2.3.3. BARGAINING POWER OF BUYERS 2.3.4. BARGAINING POWER OF SUPPLIERS 2.3.5. THREAT OF COMPETITIVE RIVALRY 2.4. KEY IMPACT ANALYSIS 2.5. MARKET ATTRACTIVENESS INDEX 2.6. VENDOR SCORECARD 2.7. INDUSTRY COMPONENTS 2.8. REGULATORY FRAMEWORK 2.9. KEY MARKET STRATEGIES 2.9.1. PRODUCT LAUNCHES & DEVELOPMENTS 2.9.2. PARTNERSHIPS & AGREEMENTS 2.10. MARKET DRIVERS 2.10.1. FAVORABLE INITIATIVES 2.10.2. AVAILABILITY OF CHEAP FEEDSTOCK 2.10.3. ABILITY OF BIOCHAR TO SEQUESTER CARBON 2.10.4. RELIA...
Read more

ITALY ALCOHOLIC READY-TO-DRINKS (RTDS) MARKET 2021-2026

    TABLE OF CONTENT 1.      ITALY ALCOHOLIC READY-TO-DRINKS (RTDS) MARKET –SUMMARY 1.1. COUNTRY SNAPSHOT 1.2. MARKET SIZE & FORECAST 1.3. MARKET DRIVING ASPECTS 1.4. MARKET RESTRAINING ASPECTS 1.5. KEY PLAYERS 2.      ITALY ALCOHOLIC READY-TO-DRINKS (RTDS) MARKET OUTLOOK 2.1. IMPACT OF COVID-19 ON ITALY ALCOHOLIC RTDS MARKET 2.2. PESTLE ANALYSIS 2.2.1.     POLITICAL 2.2.2.     ECONOMICAL 2.2.3.     SOCIAL 2.2.4.     TECHNOLOGICAL 2.2.5.     LEGAL 2.2.6.     ENVIRONMENTAL 2.3. MARKET ATTRACTIVENESS INDEX 2.4. MARKET SHARE ANALYSIS OF KEY PLAYERS 2.5. BRAND SHARE ANALYSIS 3.      ITALY ALCOHOLIC RTD MARKET SEGMENTATION - BY RTD TYPE (IN TERMS OF VALUE: $ MILLION & IN TERMS OF VOLUME: MILLION LITRES) 3.1. SPIRIT-BASED RTDS 3.2. WINE-BASED RTDS 4.    ...
Read more

GLOBAL ENTERPRISE RESOURCE PLANNING MARKET 2022-2028

    TABLE OF CONTENTS   1.      GLOBAL ENTERPRISE RESOURCE PLANNING MARKET - SUMMARY 2.      INDUSTRY OUTLOOK 2.1. IMPACT OF COVID-19 ON ENTERPRISE RESOURCE PLANNING MARKET 2.2. PARENT MARKET ANALYSIS: ENTERPRISE APPLICATION MARKET 2.3. TIMELINE OF ENTERPRISE RESOURCE PLANNING (ERP) 2.4. KEY INSIGHTS 2.4.1.     EMERGENCE OF CLOUD ERP 2.4.2.     SOCIAL NETWORKING IS GAINING IMPORTANCE AMONG ERP MERCHANTS 2.4.3.     INTEGRATED ERP IS ONE OF THE PROMINENT EMERGING TRENDS 2.4.4.     ACQUISITION HAS EMERGED AS A PRIMARY GROWTH STRATEGY 2.5. PORTER’S FIVE FORCES ANALYSIS 2.5.1.     THREAT OF NEW ENTRANTS 2.5.2.     THREAT OF SUBSTITUTES 2.5.3.     BARGAINING POWER OF BUYERS 2.5.4.     BARGAINING POWER OF SUPPLIERS 2.5.5.     THREAT OF COMPETITIVE RIVALRY 2.6. KEY...
Read more